Challenging Times for European Biotech IPOs
This article was originally published in Start Up
Executive Summary
Through the first week of May, 2005, five biotechs listed on Europe's main markets. Like their counterparts in the US, these companies have had to deal with difficult public markets and have on the whole raised much less money than they originally intended.